家庭无创正压通气与COPD临床结局的系统综述与荟萃分析
BPAP通气与不设备相比死亡风险降低(22.31% vs 28.57%;OR 0.66;95%CI 0.51-0.87;无创HMV与更少全因入院相关,死亡率无显著差异。证据质量低至中等。
要点
- 家庭BPAP通气可降低高碳酸血症COPD患者死亡风险、全因入院和插管需求。
- BPAP对生活质量无显著改善,证据不足。
- 无创HMV减少全因入院,但死亡率差异无统计学意义。
核心结论
- 在高碳酸血症COPD患者中,家庭BPAP通气与不设备相比死亡风险、全因入院和插管需求降低相关,但生活质量无显著差异;无创HMV与更少全因入院相关,死亡率无显著差异。
- 总体证据质量为低至中等,生活质量证据不足,部分结局分析基于少量研究。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、EMBASE、SCOPUS、Cochrane对照试验中心注册库、Cochrane系统综述数据库、国家指南交换所和Scopus,纳入1995年1月1日至2019年11月6日发表的英文文献。
临床怎么用
- 对于高碳酸血症COPD患者,可考虑家庭BPAP通气以降低死亡、全因入院和插管风险,但需权衡证据质量低至中等且生活质量获益不明确。
- 无创HMV可能减少全因入院,但死亡率获益不确定,决策时应结合患者具体情况和证据局限性。
局限性
- 总体证据质量为低至中等,生活质量证据不足。
- 部分结局分析基于少量研究,结果稳定性有限。
- 纳入研究包括观察性设计,可能存在偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The association of home noninvasive positive pressure ventilation (NIPPV) with outcomes in chronic obstructive pulmonary disease (COPD) and hypercapnia is uncertain. OBJECTIVE: To evaluate the association of home NIPPV via bilevel positive airway pressure (BPAP) devices and noninvasive home mechanical ventilator (HMV) devices with clinical outcomes and adverse events in patients with COPD and hypercapnia. DATA SOURCES: Search of MEDLINE, EMBASE, SCOPUS, Cochrane Central Registrar of Controlled Trials, Cochrane Database of Systematic Reviews, National Guideline Clearinghouse, and Scopus for English-language articles published from January 1, 1995, to November 6, 2019. STUDY SELECTION: Randomized clinical trials (RCTs) and comparative observational studies that enrolled adults with COPD with hypercapnia who used home NIPPV for more than 1 month were included. DATA EXTRACTION AND SYNTHESIS: Data extraction was completed by independent pairs of reviewers. Risk of bias was evaluated using the Cochrane Collaboration risk of bias tool for RCTs and select items from the Newcastle-Ottawa Scale for nonrandomized studies. MAIN OUTCOMES AND MEASURES: Primary outcomes were mortality, all-cause hospital admissions, need for intubation, and quality of life at the longest follow-up. RESULTS: A total of 21 RCTs and 12 observational studies evaluating 51 085 patients (mean [SD] age, 65.7 [2.1] years; 43% women) were included, among whom there were 434 deaths and 27 patients who underwent intubation. BPAP compared with no device was significantly associated with lower risk of mortality (22.31% vs 28.57%; risk difference [RD], -5.53% [95% CI, -10.29% to -0.76%]; odds ratio [OR], 0.66 [95% CI, 0.51-0.87]; P = .003; 13 studies; 1423 patients; strength of evidence [SOE], moderate), fewer patients with all-cause hospital admissions (39.74% vs 75.00%; RD, -35.26% [95% CI, -49.39% to -21.12%]; OR, 0.22 [95% CI, 0.11-0.43]; P < .001; 1 study; 166 patients; SOE, low), and lower need for intubation (5.34% vs 14.71%; RD, -8.02% [95% CI, -14.77% to -1.28%]; OR, 0.34 [95% CI, 0.14-0.83]; P = .02; 3 studies; 267 patients; SOE, moderate). There was no significant difference in the total number of all-cause hospital admissions (rate ratio, 0.91 [95% CI, 0.71-1.17]; P = .47; 5 studies; 326 patients; SOE, low) or quality of life (standardized mean difference, 0.16 [95% CI, -0.06 to 0.39]; P = .15; 9 studies; 833 patients; SOE, insufficient). Noninvasive HMV use compared with no device was significantly associated with fewer all-cause hospital admissions (rate ratio, 0.50 [95% CI, 0.35-0.71]; P < .001; 1 study; 93 patients; SOE, low), but not mortality (21.84% vs 34.09%; RD, -11.99% [95% CI, -24.77% to 0.79%]; OR, 0.56 [95% CI, 0.29-1.08]; P = .49; 2 studies; 175 patients; SOE, insufficient). There was no statistically significant difference in the total number of adverse events in patients using NIPPV compared with no device (0.18 vs 0.17 per patient; P = .84; 6 studies; 414 patients). CONCLUSIONS AND RELEVANCE: In this meta-analysis of patients with COPD and hypercapnia, home BPAP, compared with no device, was associated with lower risk of mortality, all-cause hospital admission, and intubation, but no significant difference in quality of life. Noninvasive HMV, compared with no device, was significantly associated with lower risk of hospital admission, but there was no significant difference in mortality risk. However, the evidence was low to moderate in quality, the evidence on quality of life was insufficient, and the analyses for some outcomes were based on small numbers of studies.
引用
- Wilson ME, Dobler CC, Morrow AS, et al. Association of Home Noninvasive Positive Pressure Ventilation With Clinical Outcomes in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis. JAMA. 2020. PMID: 32016309. doi:10.1001/jama.2019.22343
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。